JVM Co

JVM Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of JVM Co (054950.KQ) as of Nov 4, 2026 is 74.00. In the previous year, Days Payable Outstanding (DPO) was 86.52 — a change of -14.47% (lower).

Days Payable Outstanding

74.00

YoY

-14.47%

Last updated:

Days Payable Outstanding (DPO) of JVM Co is 2025 74.00 . Days Payable Outstanding (DPO) of JVM Co was 2024 86.52 . It decreases by -14.47% lower compared to the previous year.

The JVM Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
101.20 KRW
Jan 1, 2019
122.27 KRW
Jan 1, 2020
102.21 KRW
Jan 1, 2021
117.20 KRW
Jan 1, 2022
75.60 KRW
Jan 1, 2023
69.90 KRW
Jan 1, 2024
86.52 KRW
Jan 1, 2025
74.00 KRW
The JVM Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
74.00-14.47%
86.52+23.79%
69.90-7.54%
75.60-35.49%
117.20+14.66%
102.21-16.41%
122.27+20.82%
101.20+63.07%
62.06+14.79%
54.07+14.50%
47.22-9.43%
52.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Days Payable Outstanding (DPO) of JVM Co is 74.00 in 2025.

Days Payable Outstanding (DPO) of JVM Co changed from 86.52 to 74.00, representing a -14.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) JVM Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — JVM Co

All Key Metrics — JVM Co